libri scuola books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro

stewart david j. (curatore) - lung cancer:
Zoom

Lung Cancer: Prevention, Management, and Emerging Therapies




Disponibilità: Normalmente disponibile in 15 giorni
A causa di problematiche nell'approvvigionamento legate alla Brexit sono possibili ritardi nelle consegne.


PREZZO
270,98 €
NICEPRICE
257,43 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

Humana Press

Pubblicazione: 04/2012
Edizione: 1





Trama

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.




Sommario

Molecular Pathology of Lung Cancer.- Tumor Microenvironment.- Racial and Ethnic Diversity in Lung Cancer.- Pharmacogenetics of Lung Cancer.- Lung Cancer Prevention.- Adjuvant and Neoadjuvant Therapy of NSCLC.- Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer.- Management of Advanced Non-small Cell Lung Cancer: Front Line Treatment.- Chemotherapy in Previously Treated Patients with Non-small Cell Lung Cancer.- Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-small Cell Lung Cancer.- Angiogenesis Inhibitors in Lung Cancer.- Other Molecular Targeted Agents in Non-small Cell Lung Cancer.- Vaccine Therapy for Lung Cancer.- Gene-Based Therapies for Lung Cancer.- Lung Cancer Resistance to Chemotherapy.- Small Cell Carcinoma of the Lung.- Mesothelioma.- Advances in Oncology Clinical Research: Statistical and Study Design Methodologies.- Palliative Care for Patients with Lung Cancer.- The Future of Lung Cancer.










Altre Informazioni

ISBN:

9781617796845

Condizione: Nuovo
Collana: Current Clinical Oncology
Dimensioni: 235 x 155 mm
Formato: Brossura
Illustration Notes:XVI, 538 p. 30 illus., 14 illus. in color.
Pagine Arabe: 538
Pagine Romane: xvi


Dicono di noi